ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLIN Clinigen Group Plc

925.00
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 925.00 924.50 925.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Clinigen Share Discussion Threads

Showing 26 to 50 of 1400 messages
Chat Pages: Latest  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
13/12/2012
11:58
Cestnous - I don't subscribe to Shares

Regards
GHF

glasshalfull
13/12/2012
11:57
Simon

If GHF has sent you both, fine. If not let me know.

cestnous
13/12/2012
11:55
Simon Gordon - I've pinged you an email.

Regards
GHF

glasshalfull
13/12/2012
11:20
Cestnous,

Could you give a rough outline of the tips in SCSW and Shares?

What do they see as catalysts for share price outperformance?

Thanks

simon gordon
13/12/2012
07:56
Buy tip in 'Shares' mag today
cestnous
09/12/2012
09:25
Given the strength of the original tip, I fancy these as one of scsw's new year naps.
peladon
08/12/2012
12:55
Yes, read that this morning Nurdin, very encouraging.
cestnous
08/12/2012
12:44
Good to know guys..phew !

Nice little snippet in this months SCSW.The article says Numis have just released 'a weighty' 60-page note initiating the shares with a buy and 240p target.It notes however that the forecasts and target make no allowance for possible acquisitions of new licenses.Keep buying it says...

Hope we get a reaction on Monday.

nurdin
07/12/2012
15:16
I'm still here, no sign of a drug deal yet.

======

GHF,

Good to see you hear. HSP is worth a skeg, dirt cheap, just needs to move past the closure of Maltby and a small fraud in Belgium. It's more risky, but from what I can gather it is sub 5x for 2014, though I haven't got my hands on a broker note to make sure they're not wrong, it's in flux due to the uncertainty of Maltby's lost earnings.

Merry Christmas :-)

simon gordon
07/12/2012
14:45
I've also been buying here nurdin.

As a subscriber to SCSW I found their recent write-up extremely bullish and managed to grab a few sub 200p, content to await developments.

Peter George appears to have the hallmarks of a CEO worth following.

GLA

Regards,
GHF

glasshalfull
07/12/2012
14:36
Still here Nurdin; waiting patiently for the spider to catch the fly.
cestnous
07/12/2012
14:34
Things have gone very quiet here.....any holders left? :o)
nurdin
16/11/2012
15:37
Here's hoping that you may not have to wait too long, the listing prospectus talked about advanced discussions on one prospect with the hope that talks may be concluded by the end of October, if it has not fallen by the wayside it may be due any day now.....
lomax99
16/11/2012
13:54
cheers simon..quite reassuring.

All we need now is some acquisition news to put a rocket under the share price.. :o)

nurdin
15/11/2012
20:17
WSJ - 14/11/12:

The Path to Triple-Digit Growth

Every CEO wants to have double- or even triple-digit growth, but few achieve it, which is why a pharmaceuticals CEO who has managed extraordinary growth deserves attention.

Peter George is the group CEO of Clinigen, which recently topped the Sunday Times Fastest Growing Companies list with sales rising from an annualized £875,000 ($1.4 million) in 2008 to £35 million ($55.6 million) in the financial year ended June 2011. He heads the first pharmaceutical company to float in the U.K. since 2007.

Given that this is a blog aimed at the tech sector, why should you listen to a guy from pharmaceuticals? Maybe because he has achieved substantial growth not just the one time–that could be down to luck, or the market–but three times: as chief operating officer of startup UCTi, the company grew to $80 million in three years. He was executive vice president at Wolters Kluwer Health when the company went from $32 million to $110 million in three years. Maybe he is on to something.

The no-nonsense Englishman says there is no great secret. He is almost embarrassed at how obvious the answer is, he admits. It isn't technology, it isn't clever marketing. It is something much more basic.

"Growth is all about having the right people," Mr. George said at the recent open day held by Cambridge Consultants.

"It is no good going to the top of Everest with someone who hasn't been there before - you have to have people who know what internationalizing a business is all about."

But the flip side, and one he says too many CEOs realize too late, is getting rid of people who hold you back. "You have to really quickly get rid of people who resist the new world. They start resisting everything you try to do."

While some of his advice may not be directly applicable in a startup, nevertheless, his four simple lessons in the video have been shown to work.

1. Examine your market and find out what your opposition is doing. If you aren't doing it, why not?

2. Hire the right people.

3. Fire people who hold you back.

4. Make sure that everyone who works for you knows, understands, and shares your goals so that everyone feels they are playing a part in them.

On the subject of startups, Mr. George said there is a perception that growth comes from brand new companies. "In fact, 70% of companies classified as high-growth have been in existence for five years."

But innovation is at the heart of success. "Innovative companies grow twice as fast [as others]. They find new ways to satisfy their customers," he said.

"That is my focus - I look at what is it we are doing, who are our customers and how can we satisfy them better. I focus almost 100% of my energy on doing just that."

simon gordon
12/11/2012
18:17
I note that there was also a buy recommendation in last week's Shares Mag.
melf
12/11/2012
17:35
Having read the SCSW tip am keen to buy but not at this level today. So will wait for the coming days to see if I can get in a bit lower. As I'm new to this share if anyone has any other info please do share.....I suspect not as its new to market but can only ask.
the oak tree
12/11/2012
11:53
me too! QPP my best performer of 2012 thanks to SCSW tip
craffert
12/11/2012
09:56
That's true craffert, but of the seventeen scsw stocks I have chosen from their picks, three have hit stop losses, two are slightly underwater and the remaining ten are in profit between 17% and 104% (QPP). This is over a period of about 8 months. If I could do as well as that in my other portfolios, I would be more than happy.
cestnous
12/11/2012
09:14
scsw tips tend to lead to one day spikes followed by next day pullback (but still ahead)
craffert
12/11/2012
08:15
yup..had some early doors
nurdin
12/11/2012
08:13
Well SCSW seems to have done the trick.
cestnous
10/11/2012
21:19
huge positive write up in SCSW today.....expect to see fireworks on Monday. Looks like a decent company
craffert
08/11/2012
14:37
starting to move
gucci
08/11/2012
13:09
Simon, thanks for the above - I've been searching for some forecasts for the last couple of weeks.
corbeta
Chat Pages: Latest  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock